Latest press releases

The Walloon Region is investing €3.16M in a brand new treatment developed by Aquilon Pharma.

Walloon Region invests €3.16m in a new €4.3m Asthma and COPD treatment project developed by Aquilon Pharma

Aquilon Pharma is a Belgian PharmaTech company with global ambitions, engaged in the improvement of the efficacy of inhaled drugs, thanks to its breakthrough functional excipient: the HPβCD.

Get a glimpse into our company and investor data—powered by the PitchBook Platform.

Aquilon Pharma, a young Liège-based company developing innovative treatments for asthma and other respiratory diseases, has just raised 6.6 million euros for the clinical development of its products.

Aquilon Pharma, specialized in the treatment of lung diseases, raises €6.6 million for its clinical (Phase I/IIa) and commercial development…